Hypoxia-regulated angiogenic inhibitors

Trends in Cardiovascular Medicine

Volumn 19, Issue 8, 2009, Pages 252-256

  Messmer Blust, Angela ^a   An, Xiaojin ^a   Li, Jian ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN; ANGIOPOIETIN RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1; TRANSCRIPTION FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ATHEROSCLEROSIS; CELL MIGRATION; CELL PROLIFERATION; CORONARY ARTERY DISEASE; DISEASE COURSE; ENDOTHELIUM CELL; FEEDBACK SYSTEM; HOMEOSTASIS; HUMAN; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PULMONARY HYPERTENSION; REGULATORY MECHANISM; REVIEW; UPREGULATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANOXIA; HOMEOSTASIS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77952510108     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2010.02.006     Document Type: Review

References (34)

1. Abdollahi A., Hahnfeldt P., Maercker C., et al. Endostatin's antiangiogenic signaling network. Mol Cell 2004, 13:649-663.
2. Adams L.D., Geary R.L., McManus B., et al. A comparison of aorta and vena cava medial message expression by cDNA array analysis identifies a set of 68 consistently differentially expressed genes, all in aortic media. Circ Res 2000, 87:623-631.
3. An X., Jin Y., Guo H., et al. Response gene to complement 32, a novel hypoxia-regulated angiogenic inhibitor. Circulation 2009, 120:617-627.
4. Bell S.E., Mavila A., Salazar R., et al. Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling. J Cell Sci 2001, 114:2755-2773.
5. Carmeliet P., Dor Y., Herbert J.M., et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998, 394:485-490.
6. Chen G., Ray R., Dubik D., et al. The E1B 19K/Bcl-2-binding protein Nip3 is a dimeric mitochondrial protein that activates apoptosis. J Exp Med 1997, 186:1975-1983.
7. Chilov D., Camenisch G., Kvietikova I., et al. Induction and nuclear translocation of hypoxia-inducible factor-1 (HIF-1): heterodimerization with ARNT is not necessary for nuclear accumulation of HIF-1alpha. J Cell Sci 1999, 112(Pt 8):1203-1212.
8. Folkman J. Angiogenesis. Annu Rev Med 2006, 57:1-18.
9. Fong G.H. Mechanisms of adaptive angiogenesis to tissue hypoxia. Angiogenesis 2008, 11:121-140.
10. Fried R., Meyrick B., Rabinovitch M., et al. Polycythemia and the acute hypoxic response in awake rats following chronic hypoxia. J Appl Physiol 1983, 55:1167-1172.
11. Frisdal E., Gest V., Vieillard-Baron A., et al. Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension. Eur Respir J 2001, 18:838-845.
12. Hammond E.M., Giaccia A.J. The role of p53 in hypoxia-induced apoptosis. Biochem Biophys Res Commun 2005, 331:718-725.
13. Heljasvaara R., Nyberg P., Luostarinen J., et al. Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases. Exp Cell Res 2005, 307:292-304.
14. Hickey M.M., Simon M.C. Regulation of angiogenesis by hypoxia and hypoxia-inducible factors. Curr Top Dev Biol 2006, 76:217-257.
15. Jin Y., An X., Ye Z., et al. RGS5, a hypoxia-inducible apoptotic stimulator in endothelial cells. J Biol Chem 2009, 284:23436-23443.
16. Kothari S., Cizeau J., McMillan-Ward E., et al. BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF. Oncogene 2003, 22:4734-4744.
17. Liu Z.J., Shirakawa T., Li Y., et al. Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol Cell Biol 2003, 23:14-25.
18. Lobov I.B., Renard R.A., Papadopoulos N., et al. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci U S A 2007, 104:3219-3224.
19. Maisonpierre P.C., Suri C., Jones P.F., et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997, 277:55-60.
20. Morbidelli L., Donnini S., Chillemi F., et al. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin. Clin Cancer Res 2003, 9:5358-5369.
21. Oh H., Takagi H., Suzuma K., et al. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 1999, 274:15732-15739.
22. Paddenberg R., Faulhammer P., Goldenberg A., et al. Hypoxia-induced increase of endostatin in murine aorta and lung. Histochem Cell Biol 2006, 125:497-508.
23. Qin G., Kishore R., Dolan C.M., et al. Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF. Proc Natl Acad Sci U S A 2006, 103:11015-11020.
24. Semenza G.L. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 2000, 88:1474-1480.
25. Shie J.L., Wu G., Wu J., et al. RTEF-1, a novel transcriptional stimulator of vascular endothelial growth factor in hypoxic endothelial cells. J Biol Chem 2004, 279:25010-25016.
26. Simons M. Angiogenesis: where do we stand now?. Circulation 2005, 111:1556-1566.
27. Slomiany M.G., Rosenzweig S.A. Hypoxia-inducible factor-1-dependent and -independent regulation of insulin-like growth factor-1-stimulated vascular endothelial growth factor secretion. J Pharmacol Exp Ther 2006, 318:666-675.
28. Stempien-Otero A., Karsan A., Cornejo C.J., et al. Mechanisms of hypoxia-induced endothelial cell death. Role of p53 in apoptosis. J Biol Chem 1999, 274:8039-8045.
29. Suhr F., Brixius K., De Marees M., et al. Effects of short-term vibration and hypoxia during high-intensity cycling exercise on circulating levels of angiogenic regulators in humans. J Appl Physiol 2007, 103:474-483.
30. Wu G., Mannam A.P., Wu J., et al. Hypoxia induces myocyte-dependent COX-2 regulation in endothelial cells: role of VEGF. Am J Physiol Heart Circ Physiol 2003, 285:H2420-H2429.
31. Xenaki G., Ontikatze T., Rajendran R., et al. PCAF is an HIF-1alpha cofactor that regulates p53 transcriptional activity in hypoxia. Oncogene 2008, 27:5785-5796.
32. Yan S.F., Fujita T., Lu J., et al. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med 2000, 6:1355-1361.
33. Yang E., Korsmeyer S.J. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 1996, 88:386-401.
34. Yuan H.T., Khankin E.V., Karumanchi S.A., et al. Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium. Mol Cell Biol 2009, 29:2011-2022.